Nonetheless, expression of ZEB1 and other activators has been observed in GBM cells due to Wnt/β-catenin signaling [42], that increases cell motility in an epithelial-to-mesenchymal(-like) transition manner [43]. This evidence concerns the gene ZEB1 and glioblastoma.